Location History:
- Balmain, AU (2002)
- New South Wales, AU (2003)
- Caulfield Nth., AU (2010)
- Seddon, AU (2006 - 2011)
- Melbourne, AU (2009 - 2013)
- Caulfield North, AU (2014 - 2015)
- Richmond, AU (2012 - 2016)
- Caulfield, AU (2016)
- Notting Hill, AU (2017)
Company Filing History:
16 out of 18 
4 out of 4 
1 out of 1 
Years Active: 2002-2017
Title: Christopher John Burns: A Pioneer in Kinase Inhibitor Development
Introduction:
Christopher John Burns, based in Richmond, Australia, is an innovative inventor with an impressive portfolio that includes 24 patents. His work primarily focuses on the development of compounds aimed at treating various disease states, particularly through the modulation of microtubule polymerization and the inhibition of protein kinases.
Latest Patents:
Burns’ latest patents include groundbreaking inventions such as "Substituted 1,2,4-triazines as tubulin inhibitors." This patent describes compounds designed to modulate microtubule polymerization, making them significant for treating related disease states. Additionally, he has developed patents for "N-containing heterocyclic compounds" which serve as inhibitors of protein kinases, including JAK kinases. These compounds are especially selective for JAK1, JAK2, JAK3, and TYK2 kinases, providing therapeutic avenues for various kinase-associated diseases, such as immunological disorders and cancer.
Career Highlights:
Throughout his career, Christopher has made significant contributions to pharmaceutical research. He has worked with prominent companies, including Ym Biosciences Australia Pty Ltd. and Cytopia Research Pty Ltd, where he utilized his expertise to advance the development of novel therapeutic compounds. His extensive experience in the field has positioned him as a leading inventor in the area of drug development.
Collaborations:
Collaboration has been key in Burns' career. He has worked alongside notable colleagues such as Andrew Frederick Wilks and Xianyong Bu, fostering an environment of innovation and shared expertise. These partnerships have contributed to the successful development of his patents and have played a vital role in his research endeavors.
Conclusion:
Christopher John Burns exemplifies the spirit of innovation in the pharmaceutical industry. With his vast array of patents and collaborations, he has made significant strides in the treatment of diseases through kinase inhibitors and tubulin modulation. His ongoing contributions are sure to impact the field of medicine and therapeutic development for years to come.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.